Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.

Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E.

Blood. 2011 Jan 6;117(1):165-74. doi: 10.1182/blood-2010-01-265272. Epub 2010 Sep 27.

2.

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

Kis LL, Takahara M, Nagy N, Klein G, Klein E.

Immunol Lett. 2006 Apr 15;104(1-2):83-8. Epub 2005 Dec 1. Review.

PMID:
16386314
3.

In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.

Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E.

Int J Cancer. 2005 Mar 1;113(6):937-45.

5.

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.

Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.

J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18.

PMID:
22921685
6.

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.

Kis LL, Salamon D, Persson EK, Nagy N, Scheeren FA, Spits H, Klein G, Klein E.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):872-7. doi: 10.1073/pnas.0912920107. Epub 2009 Dec 22.

7.

A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, McClellan MJ, West MJ, Farrell PJ.

J Virol. 2014 Aug;88(16):8743-53. doi: 10.1128/JVI.01000-14. Epub 2014 May 21.

9.

Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.

Tang Y, Lu S, Gan X, Liu F, Zhang Y, Luo C, Pan Y, Hong L, Gan R.

Oncol Rep. 2016 Feb;35(2):905-11. doi: 10.3892/or.2015.4401. Epub 2015 Nov 5.

PMID:
26548532
10.
13.
14.

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.

Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.

Int J Cancer. 1994 Apr 15;57(2):240-4.

PMID:
8157362
15.

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.

Am J Pathol. 1993 Oct;143(4):1072-85.

16.
17.
18.

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.

J Virol. 1988 Oct;62(10):3747-55.

19.

Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.

Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.

J Med Virol. 2001 Sep;65(1):114-20.

PMID:
11505452
20.

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.

Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E.

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7.

Supplemental Content

Support Center